GenMute™ siRNA Transfection Reagent for HeLa Cells

SKU:BHT2200040
Research Validated
Overview
Click light‑blue chips for details
GenMute™ siRNA Transfection Reagent for HeLa Cells is a SignaGen Laboratories reagent pre-optimized for siRNA delivery into HeLa cells, so the usual optimization step is not needed. Few human cervical cancer cell lines see as much biomedical research use as HeLa, which turns up throughout work on gene function, cancer biology, signal transduction, virology, and drug discovery — yet general-purpose reagents can struggle to give consistent knockdown without toxicity.
Transfection Type siRNA Transfection
Application Setting In Vitro
Optimized Cell Line HeLa
Storage 4 °C
Shelf Life 24 months
Options selector
Catalog no. Size
SL100568-HELA-0P1ML 0.1 mL
SL100568-HELA-0P5ML 0.5 mL
SL100568-HELA-1P0ML 1.0 mL
SL100568-HELA-1P0MLX5 1.0 mL x 5
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: 4 variants available — select size from the variant selector.
  • Lead time: options listed in "Availability Content"; other statuses may take longer.
  • Storage: Store at 4 °C. If stored properly, the product is stable for 24 months or longer
  • Shipping: Please contact us to confirm shipping conditions for this product.
  • Upon receipt: refrigerate upon receipt.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Storage 4 °C
Catalog no. (Mfr.) SL100568-HELA
Main SKU BHT2200040

Product Overview

Few human cervical cancer cell lines see as much biomedical research use as HeLa, which turns up throughout work on gene function, cancer biology, signal transduction, virology, and drug discovery — yet general-purpose reagents can struggle to give consistent knockdown without toxicity. GenMute™ siRNA Transfection Reagent for HeLa Cells answers that with conditions tuned specifically in advance for efficient siRNA delivery into these cells. Engineering of the formulation targets maximal cellular uptake and intracellular release of siRNA, with cell viability and normal morphology preserved.

Transfection efficiency runs high and cytotoxicity low, so gene silencing comes out robust and reproducible for downstream in vitro applications: pathway analysis, target validation, functional assays.

Specifications

Transfection Type siRNA Transfection
Application Setting In Vitro
Pre-Optimized Yes — Pre-Optimized for Specific Cell Type
Optimized Cell Line HeLa
Storage Store at 4 °C. If stored properly, the product is stable for 24 months or longer

Optimal Transfection Conditions

Cell culture medium DMEM with 4.5 g/L glucose, 10% FBS
Cell confluency on the day of transfection ~70%
Optimal siRNA concentration 10.0 nM
Diluent for siRNA and GenMute™ Reagent 1 x GenMute™ Transfection Buffer
Incubation Time to Form GenMute™/siRNA Complex ~15 min at RT
Maximal Silencing Timeline 72 hrs
Reporter Gene Silencing Efficiency (% ) Renilla Luciferase 90%

Kit Contents

  • GenMute™ Reagent, 1.0 mL, sufficient for ~833 reactions based on transfecting 20 pmol siRNA or miRNA mimics in a 24-well plate
  • GenMute™ Transfection Buffer (5x), formulated for maximal transfection efficiency, 8.0 mL to make 40 mL working solution

Applications

This siRNA transfection reagent supports gene silencing experiments including RNAi screening, target validation, pathway analysis, and functional genomics studies. Effective delivery of siRNA, miRNA, and other small RNA molecules.

Safety & Handling

For Research Use Only (RUO) — Not for diagnostic or therapeutic use. Handle reagents according to institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for detailed handling and disposal instructions.
Q.What type of nucleic acids can GenMute™ siRNA Transfection Reagent for HeLa Cells deliver?
A.This reagent is optimized for siRNA delivery and can also be used with other small RNA molecules such as miRNA and shRNA for gene silencing applications.
Q.How should I store GenMute™ siRNA Transfection Reagent for HeLa Cells?
A.Store at 4 °C. If stored properly, the product is stable for 24 months or longer Follow the product datasheet for detailed storage and stability information.
Q.Do I need to optimize transfection conditions with this product?
A.No. GenMute™ siRNA Transfection Reagent for HeLa Cells is pre-optimized for HeLa cells, so optimization is not required. Follow the provided protocol for best results.
Q.What is included with GenMute™ siRNA Transfection Reagent for HeLa Cells?
A.The vendor lists: GenMute™ Reagent, 1.0 mL, sufficient for ~833 reactions based on transfecting 20 pmol siRNA or miRNA mimics in a 24-well plate; GenMute™ Transfection Buffer (5x), formulated for maximal transfection efficiency, 8.0 mL to make 40 mL working solution.
Q.What are HeLa cells?
A.Few human cervical cancer cell lines see as much biomedical research use as HeLa, which turns up throughout work on gene function, cancer biology, signal transduction, virology, and drug discovery — yet general-purpose reagents can struggle to give consistent knockdown without toxicity. Engineering of the formulation targets maximal cellular uptake and intracellular release of siRNA, with cell viability and normal morphology preserved.
Q.Is this product suitable for diagnostic or therapeutic use?
A.No. This product is for Research Use Only (RUO) and is not intended for diagnostic, therapeutic, or clinical applications.

Can't Find What You're Looking For? We can help you source the best match or customize a transfection solution for your study. Options may include pre-optimized formulations for a cell line not listed here, matching transfection buffer supplied with the reagent, DNA, siRNA or in vivo formats within the same reagent family, and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.

Du J, Liao W, Wang H, et al.. MDIG-mediated H3K9me3 demethylation upregulates Myc by activating OTX2 and facilitates liver regeneration. Signal Transduct Target Ther (2023) 8(1), 351-351.. 10.1038/s41392-023-01575-5

Xu T, Ma Q, Li Y, et al.. A small molecule inhibitor of the UBE2F-CRL5 axis induces apoptosis and radiosensitization in lung cancer. Signal Transduct Target Ther (2022) 7(1), 354-354.. 10.1038/s41392-022-01182-w

Sladitschek-Martens H, Guarnieri A, Brumana G, et al.. YAP/TAZ activity in stromal cells prevents ageing by controlling cGAS-STING. Nature (2022) 607(7920), 790-798.. 10.1038/s41586-022-04924-6

Meunier E, Dick M, Dreier R, et al.. Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. Nature (2014) 509(7500), 366-70.. 10.1038/nature13157

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today